These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
99 related items for PubMed ID: 1304459
1. Detection of antigens associated with lung carcinoma in sera by monoclonal antibodies WLA-2C4 and CL-3. Wang DS, Huang W, Yuan M, Shi JQ. Chin Med J (Engl); 1992 Nov; 105(11):905-8. PubMed ID: 1304459 [Abstract] [Full Text] [Related]
2. Distribution of lung adenocarcinoma-associated antigens in human tissues and sera defined by monoclonal antibodies KM-52 and KM-93. Shitara K, Hanai N, Yoshida H. Cancer Res; 1987 Mar 01; 47(5):1267-72. PubMed ID: 3545444 [Abstract] [Full Text] [Related]
3. Detection of tumor-associated antigens in the sera of lung cancer patients by three monoclonal antibodies. Hirota M, Fukushima K, Terasaki PI, Terashita GY, Galton J, Kawahara M. Cancer Res; 1985 Dec 01; 45(12 Pt 1):6453-6. PubMed ID: 2998602 [Abstract] [Full Text] [Related]
4. [Ca 19-9 and Ca 50 in the diagnosis of bronchial carcinoma: comparison with CEA]. Pecchio F, Rapellino M, Oliaro A, Moscato D, Adamo R, Albertino B, Lo Faso C, Faga C, Borasio P. Minerva Med; 1988 Mar 01; 79(3):183-6. PubMed ID: 2834670 [Abstract] [Full Text] [Related]
5. Generation of monoclonal antibodies against human lung squamous cell carcinoma and adenocarcinoma using mice rendered tolerant to normal human lung. Hanai N, Shitara K, Yoshida H. Cancer Res; 1986 Sep 01; 46(9):4438-43. PubMed ID: 3731100 [Abstract] [Full Text] [Related]
6. Complementary reactivities of anti-carcinoembryonic antigen and antitumor-associated glycoprotein 72 monoclonal antibodies in lung carcinomas. Battista P, Muraro R, Mammarella S, Curia MC, Colasante A, Rosini S, Lesti G, Sacco R, French D, Frati L. Cancer Res; 1990 Nov 01; 50(21):6987-94. PubMed ID: 1698547 [Abstract] [Full Text] [Related]
7. [Using two monoclonal antibodies to detect lung carcinoma associated antigen in the sera of patients with lung cancer by BA-ELISA]. Xue W, Hou J. Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1991 Feb 01; 13(1):63-7. PubMed ID: 1652380 [Abstract] [Full Text] [Related]
8. [Clinical evaluation of serum carbohydrate antigen 19-9 in carcinoma of the lung--a comparison with carcinoembryonic antigen]. Hayashibe A, Kodama T, Nishiwaki Y, Kudou H, Inoue Y, Nukariya N, Kaguraoka H, Kuroki M, Takahashi K, Nishiyama Y. Gan To Kagaku Ryoho; 1987 Mar 01; 14(3 Pt 1):711-5. PubMed ID: 3030198 [Abstract] [Full Text] [Related]
9. Immunohystochemical expression of cancer/testis antigens (MAGE-A3/4, NY-ESO-1) in non-small cell lung cancer: the relationship with clinical-pathological features. Grah J, Samija M, Juretić A, Sarcević B, Sobat H. Coll Antropol; 2008 Sep 01; 32(3):731-6. PubMed ID: 18982744 [Abstract] [Full Text] [Related]
10. Monoclonal anti-CEA antibodies in the discrimination between primary pulmonary adenocarcinoma and colon carcinoma metastatic to the lung. Ghoneim AH, Brisson ML, Fuks A, Mobasher AA, Kreisman H. Mod Pathol; 1990 Sep 01; 3(5):613-8. PubMed ID: 2235987 [Abstract] [Full Text] [Related]
11. Detection of a novel lung adenocarcinoma--associated serum antigen defined by two monoclonal antibodies, KM 432 and KM 227. Shitara K, Hanai N, Yoshida H. Anticancer Res; 1993 Sep 01; 13(3):579-86. PubMed ID: 7686360 [Abstract] [Full Text] [Related]
12. Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma. Kohno N, Akiyama M, Kyoizumi S, Hakoda M, Kobuke K, Yamakido M. Jpn J Clin Oncol; 1988 Sep 01; 18(3):203-16. PubMed ID: 3411786 [Abstract] [Full Text] [Related]
13. [Value of fecal detection of cancer-associated antigens using monoclonal antibodies in the diagnosis of colorectal cancer]. Yuan M. Zhonghua Wai Ke Za Zhi; 1990 Aug 01; 28(8):497-500, 511-2. PubMed ID: 2086118 [Abstract] [Full Text] [Related]
14. [Detection and characterization of antigen component of circulating immune complex in sera from patients with lung cancer by monoclonal and polyclonal antibodies]. Xue W, Hou J. Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1991 Apr 01; 13(2):96-100. PubMed ID: 1652382 [Abstract] [Full Text] [Related]
15. Preferential expression of immunoreactive fucosylceramide in adenocarcinoma of the lung. Yamada H, Ishihara H, Kitagawa H, Kawabata Y, Itoyama S, Sugawara I. Cancer Res; 1992 Aug 15; 52(16):4408-12. PubMed ID: 1322788 [Abstract] [Full Text] [Related]
16. Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma. Bolli M, Kocher T, Adamina M, Guller U, Dalquen P, Haas P, Mirlacher M, Gambazzi F, Harder F, Heberer M, Sauter G, Spagnoli GC. Ann Surg; 2002 Dec 15; 236(6):785-93; discussion 793. PubMed ID: 12454517 [Abstract] [Full Text] [Related]
17. [The expression of monoclonal antibody KM-93 reactive antigen in human lung carcinoma--an immunohistochemical evaluation]. Sasaki K, Matsumura K, Ogino T, Tsuji T, Shinozaki F, Takahashi M. Gan No Rinsho; 1988 Jul 15; 34(8):965-8. PubMed ID: 2457119 [Abstract] [Full Text] [Related]
18. Pulmonary metastases of colonic carcinoma. Distinction from pulmonary adenocarcinoma. Flint A, Lloyd RV. Arch Pathol Lab Med; 1992 Jan 15; 116(1):39-42. PubMed ID: 1734831 [Abstract] [Full Text] [Related]
19. [A clinical evaluation using ELISA of monoclonal antibodies to CEA in the serum of patients with lung cancer]. Cha RJ. Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1986 Jun 15; 9(3):133-5, 188. PubMed ID: 3792145 [No Abstract] [Full Text] [Related]
20. Comparative studies of CAM 123-6 and carcinoembryonic antigen for the serological detection of pulmonary adenocarcinoma. Kohno N, Hirasawa Y, Kondo K, Fujioka S, Fujino S, Abe M, Yokoyama A, Hiwada K, Watanabe K, Nishimura J. Cancer Detect Prev; 1997 Jun 15; 21(2):124-8. PubMed ID: 9101072 [Abstract] [Full Text] [Related] Page: [Next] [New Search]